True Beauty Ventures

Investment decisions are made by Co-Founders and Managing Partners Rich Gersten and Cristina Nuñez. Gersten brings institutional investment experience from his tenure as a partner at L Catterton, the largest consumer-focused private equity firm globally, while Nuñez contributes direct operating experience as a beauty brand founder and investor. The firm's small senior team means deal decisions are concentrated at the partner level without a formal investment committee structure of extended partners.

The firm relies heavily on founder referrals and relationships within the beauty operator ecosystem — including alumni networks from L'Oréal, Estée Lauder, and Unilever. Because both managing partners are known quantities in the beauty community, a meaningful share of deal flow arrives inbound from founders who have been advised to raise from a fund that understands category-specific metrics. True Beauty also cultivates relationships with beauty-focused incubators and contract manufacturers who see brands before they reach institutional Series A radar.

True Beauty Ventures is structured as an institutional private equity firm that raises capital from external limited partners. It is not a family office. The firm closed a second fund in 2023, confirming that LPs — likely including family offices, fund-of-funds, and strategic beauty-aligned investors — view the single-category mandate as institutionally investable rather than a niche sidecar.

The firm primarily invests through direct equity, typically leading or co-leading early-stage rounds. For certain service-layer or lower-capital-intensity businesses, the firm has structured revenue-share or hybrid instruments, though equity remains the default alignment mechanism. The firm does not participate in pure debt, venture debt, or fund-of-fund commitments.

The firm targets founder-led brands in color cosmetics, clinical skincare, hair care, fragrance, ingestible wellness, and the beauty-adjacent technology and services layer. It favors brands with high organic retention, strong community engagement, and repeat-purchase dynamics that resemble health-and-wellness subscriptions rather than fashion-driven consumer discretionary categories. The firm generally avoids legacy department-store counter brands without a direct-to-consumer motion.

The firm avoids categories that operate on pure advertising arbitrage without brand defensibility — typically, this means avoiding direct competitors to Amazon aggregator-platform brands. It also does not invest in medical aesthetics devices that require FDA clearance, pharmaceutical cosmetics, or salon-chain rollups, preferring to stay in asset-light brand and technology plays where the team's operator experience provides a direct edge.

The firm's most notable exit is K18 Hair, a biotech-driven hair repair brand that was acquired by Unilever in February 2024. The transaction, announced by Unilever as a growth addition to its prestige beauty portfolio, validated True Beauty's thesis that science-backed, community-loved beauty brands can produce venture-scale exits. Exit terms were not disclosed, but the acquisition came roughly three years after the firm's founding, compressing the typical venture-to-liquidity timeline significantly.